AMDHD2
Basic information
Region (hg38): 16:2520357-2531422
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AMDHD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 15 | 18 | ||||
Total | 0 | 0 | 35 | 4 | 0 |
Variants in AMDHD2
This is a list of pathogenic ClinVar variants found in the AMDHD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-2520486-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
16-2520487-C-T | not specified | Uncertain significance (Aug 30, 2022) | ||
16-2520489-C-T | not specified | Uncertain significance (Aug 04, 2023) | ||
16-2520887-A-G | not specified | Uncertain significance (Nov 07, 2023) | ||
16-2521013-A-T | not specified | Uncertain significance (Jun 22, 2021) | ||
16-2521016-G-A | not specified | Uncertain significance (Apr 04, 2023) | ||
16-2521049-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
16-2521089-C-T | not specified | Uncertain significance (Sep 14, 2023) | ||
16-2527603-G-T | not specified | Uncertain significance (May 30, 2023) | ||
16-2527803-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
16-2527826-G-A | not specified | Uncertain significance (Mar 13, 2023) | ||
16-2527842-C-T | not specified | Uncertain significance (Jun 01, 2023) | ||
16-2527913-C-T | Likely benign (Jun 01, 2022) | |||
16-2527974-G-C | not specified | Uncertain significance (May 08, 2024) | ||
16-2528245-C-T | not specified | Uncertain significance (Mar 23, 2023) | ||
16-2528365-C-T | not specified | Uncertain significance (Nov 09, 2021) | ||
16-2528463-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
16-2528497-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
16-2528566-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
16-2528616-G-A | not specified | Uncertain significance (Aug 12, 2021) | ||
16-2528679-C-G | not specified | Uncertain significance (Aug 12, 2022) | ||
16-2528716-C-G | not specified | Uncertain significance (Sep 16, 2021) | ||
16-2529492-G-A | not specified | Uncertain significance (May 15, 2024) | ||
16-2529522-T-G | not specified | Uncertain significance (Aug 02, 2021) | ||
16-2530282-C-G | not specified | Uncertain significance (Aug 23, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AMDHD2 | protein_coding | protein_coding | ENST00000413459 | 11 | 11066 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00231 | 0.982 | 125675 | 0 | 25 | 125700 | 0.0000994 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.520 | 341 | 369 | 0.924 | 0.0000233 | 3732 |
Missense in Polyphen | 79 | 121.27 | 0.65143 | 1220 | ||
Synonymous | -3.74 | 226 | 165 | 1.37 | 0.0000115 | 1313 |
Loss of Function | 2.12 | 7 | 16.2 | 0.431 | 6.93e-7 | 196 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000188 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000111 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000838 | 0.0000791 |
Middle Eastern | 0.000111 | 0.000109 |
South Asian | 0.000360 | 0.000359 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes the N-glycolyl group from N- glycolylglucosamine 6-phosphate (GlcNGc-6-P) in the N- glycolylneuraminic acid (Neu5Gc) degradation pathway. Although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded. {ECO:0000269|PubMed:22692205}.;
- Pathway
- Amino sugar and nucleotide sugar metabolism - Homo sapiens (human);Sialuria or French Type Sialuria;Sialuria or French Type Sialuria;Amino Sugar Metabolism;G(M2)-Gangliosidosis: Variant B, Tay-sachs disease;Tay-Sachs Disease;Salla Disease/Infantile Sialic Acid Storage Disease;<i>N</i>-acetylglucosamine degradation II;Post-translational protein modification;Metabolism of proteins;<i>N</i>-acetylglucosamine degradation I;Synthesis of UDP-N-acetyl-glucosamine;Synthesis of substrates in N-glycan biosythesis;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein;Asparagine N-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.198
- rvis_EVS
- -0.2
- rvis_percentile_EVS
- 39.21
Haploinsufficiency Scores
- pHI
- 0.172
- hipred
- N
- hipred_score
- 0.187
- ghis
- 0.489
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Amdhd2
- Phenotype
Gene ontology
- Biological process
- carbohydrate metabolic process;N-acetylglucosamine catabolic process;UDP-N-acetylglucosamine biosynthetic process;N-acetylneuraminate catabolic process
- Cellular component
- nucleus;cytosol
- Molecular function
- protein binding;N-acetylglucosamine-6-phosphate deacetylase activity;metal ion binding;N-acetylgalactosamine-6-phosphate deacetylase activity